Stealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide in Geographic Atrophy at the Clinical Trials at the Summit Meeting 2022 Press Release / May 23, 2022June 3, 2024
Stealth Biotherapeutics Announces Data from ReCLAIM-2 Phase 2 Trial of Elamipretide in Geographic Atrophy Press Release / May 2, 2022June 3, 2024
Last Patient Completes Treatment in Stealth BioTherapeutics’ Phase 2 Geographic Atrophy Clinical Trial Press Release / February 15, 2022June 3, 2024
